Kaplan Fox Encourages Microvast Holdings, Inc. (NASDAQ: MVST) Investors Seeking Recovery to Contact the Firm Before September 21, 2026

Microvast faces a proposed securities class action alleging it overstated its margin prospects and ability to complete the Huzhou Phase 3.2 manufacturing expansion by year-end 2025. The complaint cites Microvast's March 16, 2026 disclosure of quarterly gross margin falling to about 1% from 36% a year earlier and revenue declining 15% year over year to $96.5 million, amid inventory impairment charges and customer rollout delays. The case covers investors who acquired MVST securities from April 1, 2025 through March 16, 2026, with a September 21, 2026 lead-plaintiff deadline.

Analysis

This is not a new fundamental disclosure; it is a plaintiff-firm solicitation following information already available to the market. The near-term incremental effect on MVST should therefore be primarily liquidity- and sentiment-driven rather than a material change in operating value. With a micro-cap battery manufacturer, litigation can nevertheless matter indirectly: it raises D&O costs, consumes management bandwidth, and makes equity financing more difficult precisely when inventory write-downs and delayed customer ramps imply a need to preserve cash.

The more consequential issue is whether the inventory impairment reflects a one-off mismatch in ESS specifications or evidence that the company lacks durable qualification and demand visibility. If the latter, future revenue needs to be discounted not only for lower volume but for higher working-capital intensity and recurring obsolescence risk; a low-margin hardware business cannot absorb repeated impairments without balance-sheet stress. Commercial-vehicle and stationary-storage peers with diversified customer bases—such as FLNC in storage and FREY/AMPX as higher-beta battery proxies—could benefit at the margin from customer procurement shifting toward suppliers with clearer delivery records, though there is no evidence yet of direct share transfer.

Consensus may overreact to the lawsuit headline itself while underreacting to the financing consequence of the underlying execution problems. The key 1-3 month catalyst is the next earnings release: cash burn, inventory balance, impairment recurrence, customer backlog conversion, and timing/capex for Chinese capacity are more important than litigation milestones. Over 6-18 months, a credible gross-margin recovery without further write-downs would challenge the bear case; conversely, another inventory charge, delayed capacity qualification, or a going-concern/liquidity warning would make downside nonlinear.

Key Decisions for Investors

• Do not establish a fresh directional MVST short solely on the legal filing; the informational content is low and borrow/liquidity can make a short expensive. Reassess after the next earnings release if inventory rises, operating cash burn accelerates, or gross margin remains below 10%.
• For existing MVST longs, reduce exposure into the next results unless management provides verifiable inventory aging, customer acceptance/qualification data, and a funded path to capacity completion. Thesis is falsified on the bullish side by a second material impairment or an equity raise at a substantial discount.
• Use a relative-risk expression rather than a broad EV short: long a diversified battery/energy-storage exposure such as FLNC or LIT versus a small MVST underweight, sized modestly for high idiosyncratic volatility, over a 1-3 month earnings window.
• Set an event-driven alert for MVST disclosures on unrestricted cash, inventory turns, and customer platform launches. A sequential inventory reduction paired with positive operating cash flow and gross-margin recovery above 15% would warrant closing any bearish relative position.